histamine has been researched along with chronic COVID syndrome in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "72% of patients with long COVID who received HRA reported clinical improvement, although T cell profiling did not clearly distinguish those who responded to HRA." | 1.72 | Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. ( Gant, V; Glynne, P; Gupta, R; Tahmasebi, N, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glynne, P | 1 |
| Tahmasebi, N | 1 |
| Gant, V | 1 |
| Gupta, R | 1 |
| Arun, S | 1 |
| Storan, A | 1 |
| Myers, B | 1 |
2 other studies available for histamine and chronic COVID syndrome
| Article | Year |
|---|---|
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines.
Topics: Adult; Aged; COVID-19; Female; Histamine; Histamine Antagonists; Humans; Male; Middle Aged; Post-Acu | 2022 |
Mast cell activation syndrome and the link with long COVID.
Topics: COVID-19; Histamine; Humans; Mast Cell Activation Syndrome; Mast Cells; Neoplasm Recurrence, Local; | 2022 |